CLINICAL TRIAL OF METHYSERGIDE AND OTHER PREPARATIONS IN THE MANAGEMENT OF MIGRAINE.
作者信息
CURRAN D A, LANCE J W
出版信息
J Neurol Neurosurg Psychiatry. 1964 Oct;27(5):463-9. doi: 10.1136/jnnp.27.5.463.
Abstract
摘要
相似文献
1
CLINICAL TRIAL OF METHYSERGIDE AND OTHER PREPARATIONS IN THE MANAGEMENT OF MIGRAINE.麦角新碱及其他制剂治疗偏头痛的临床试验
J Neurol Neurosurg Psychiatry. 1964 Oct;27(5):463-9. doi: 10.1136/jnnp.27.5.463.
2
MIGRAINOUS NEURALGIA.偏头痛性神经痛
N Z Med J. 1964 Dec;63:774-9.
3
TREATMENT OF MIGRAINE.偏头痛的治疗
Mod Treat. 1964 Nov;1:1363-74.
4
METHYSERGIDE IN THE MIGRAINE SYNDROME.偏头痛综合征中的麦角新碱。
Clin Pharmacol Ther. 1964 Mar-Apr;5:201-4. doi: 10.1002/cpt196452201.
5
METHYSERGIDE INDUCED DEGRANULATION OF THE BASOPHIL LEUKOCYTE IN MAN.麦角酰二乙胺诱导人体嗜碱性白细胞脱粒。
J Invest Dermatol. 1964 Dec;43:491-8. doi: 10.1038/jid.1964.191.
6
DRUG TREATMENT OF MIGRAINE HEADACHE.偏头痛的药物治疗
Wis Med J. 1964 Feb;63:132-3.
7
TREATMENT OF MIGRAINE ATTACKS: A COMPARATIVE STUDY.偏头痛发作的治疗：一项对比研究。
Headache. 1964 Oct;4:250-4. doi: 10.1111/j.1526-4610.1964.hed0403250.x.
8
CLINICAL STUDIES ON THE TREATMENT OF VASCULAR HEADACHES, A PROGRESS REPORT ON METHYSERGIDE (SANSERT).血管性头痛治疗的临床研究，麦角新碱（Sansert）进展报告
Headache. 1965 Jan;5:261-71. doi: 10.1111/j.1526-4610.1965.hed0404261.x.
9
THE OTOLARYNGOLOGIST AND THE COMMON HEADACHE SYNDROMES.耳鼻喉科医生与常见头痛综合征
Trans Am Acad Ophthalmol Otolaryngol. 1963 Nov-Dec;67:766-9.
10
DRUGS FOR HEADACHE OF MIGRAINOUS, VASCULAR OR MUSCULAR ORIGIN.用于偏头痛性、血管性或肌肉性头痛的药物。
Can Med Assoc J. 1964 Jul 25;91(4):175-6.
引用本文的文献
1
Migraine, Allergy, and Histamine: Is There a Link?偏头痛、过敏与组胺：它们之间有关联吗？
J Clin Med. 2023 May 19;12(10):3566. doi: 10.3390/jcm12103566.
2
Recent advances in understanding adverse effects associated with drugs targeting the serotonin receptor, 5-HT GPCR.在理解与靶向5-羟色胺受体（5-HT GPCR）的药物相关的不良反应方面的最新进展。
Front Glob Womens Health. 2022 Dec 8;3:1012463. doi: 10.3389/fgwh.2022.1012463. eCollection 2022.
3
Histamine and migraine revisited: mechanisms and possible drug targets.组胺和偏头痛再探：机制和可能的药物靶点。
J Headache Pain. 2019 Mar 25;20(1):30. doi: 10.1186/s10194-019-0984-1.
4
Pathogenesis of chronic cluster headache and bouts: role of tryptamine, arginine metabolism and α-agonists.慢性丛集性头痛及其发作的发病机制：色胺、精氨酸代谢及α-激动剂的作用
Neurol Sci. 2017 May;38(Suppl 1):37-43. doi: 10.1007/s10072-017-2862-4.
5
Tryptamine levels are low in plasma of chronic migraine and chronic tension-type headache.慢性偏头痛和慢性紧张型头痛患者血浆中的色胺水平较低。
Neurol Sci. 2014 Dec;35(12):1941-5. doi: 10.1007/s10072-014-1867-5. Epub 2014 Jul 14.
6
Antagonism by methysergide of vascular effects of 5-hydroxytryptamine in man.甲基麦角新碱对人体5-羟色胺血管效应的拮抗作用。
Br J Pharmacol Chemother. 1967 Aug;30(3):518-30. doi: 10.1111/j.1476-5381.1967.tb02158.x.
7
Excretion of 5-hydroxyindolyl acetic acid (5HIAA) in migraine.偏头痛患者中5-羟吲哚乙酸（5HIAA）的排泄情况。
J Neurol Neurosurg Psychiatry. 1966 Feb;29(1):85-90. doi: 10.1136/jnnp.29.1.85.
8
Prophylaxis of recurrent headache.复发性头痛的预防
Br Med J. 1969 Jan 4;1(5635):5-6.
9
An assessment of platelet aggregation induced by 5-hydroxytryptamine.5-羟色胺诱导的血小板聚集评估。
J Clin Pathol. 1971 Apr;24(3):250-8. doi: 10.1136/jcp.24.3.250.
10
Migraine--general management.偏头痛——综合管理
Br Med J. 1971 Jun 26;2(5764):756-7. doi: 10.1136/bmj.2.5764.756.
本文引用的文献
1
Vasodilating headache: a suggested classification and results of prophylactic treatment with UML 491 (methysergide).
Proc Staff Meet Mayo Clin. 1962 Aug 15;37:433-43.
2
Prophylactic and therapeutic properties of 1-methyl-lysergic acid butanolamide in migraine.1-甲基麦角酰胺对偏头痛的预防和治疗作用
Int Arch Allergy Appl Immunol. 1959;15:300-7. doi: 10.1159/000229055.
3
Observations on 500 cases of migraine and allied vascular headache.500例偏头痛及相关血管性头痛的观察
J Neurol Neurosurg Psychiatry. 1960 Feb;23(1):23-32. doi: 10.1136/jnnp.23.1.23.
4
Effect of serotonin in migraine patients.血清素对偏头痛患者的影响。
Neurology. 1960 Feb;10:107-11. doi: 10.1212/wnl.10.2.107.
5
[Serotonin antagonists in the therapy of migraine and Bing's erythroprosopalgia or the Horton syndrome].[5-羟色胺拮抗剂在偏头痛及宾氏红斑性面痛或霍顿综合征治疗中的应用]
Schweiz Med Wochenschr. 1960 Feb 27;90:203-9.
6
Headache and hydration; the significance of two varieties of fluid accumulation in patients with vascular headache of the migraine type.
AMA Arch Intern Med. 1955 Aug;96(2):142-52. doi: 10.1001/archinte.1955.00250130016002.
7
CUTANEOUS BLOOD FLOW IN VASCULAR HEADACHES OF THE MIGRAINE TYPE.偏头痛型血管性头痛中的皮肤血流
Neurology. 1964 Jan;14:24-30. doi: 10.1212/wnl.14.1.24.
8
METHYSERGIDE IN THE PROPHYLAXIS OF MIGRAINE.麦角新碱预防偏头痛的研究
Lancet. 1964 Mar 7;1(7332):523-4. doi: 10.1016/s0140-6736(64)92910-1.
9
An evaluation of methysergide in the prevention of migraine and other vascular headaches.麦角酸二乙胺预防偏头痛及其他血管性头痛的评估。
Med J Aust. 1963 Jun 1;50(1):814-8.
10
Cerebrospinal fluid serotonin in brain tumor and other neurological disorders determined by a spectrophotofluorometric technique.
J Lab Clin Med. 1962 Feb;59:320-6.
Zotero 插件